FY2025 EPS Estimates for Biotricity Lowered by HC Wainwright

Biotricity, Inc. (NASDAQ:BTCY) – Investment analysts at HC Wainwright dropped their FY2025 earnings per share estimates for Biotricity in a research report issued to clients and investors on Monday, November 18th. HC Wainwright analyst K. Dede now forecasts that the company will earn ($0.67) per share for the year, down from their prior forecast of ($0.43). HC Wainwright has a “Neutral” rating on the stock. The consensus estimate for Biotricity’s current full-year earnings is ($0.43) per share.

Biotricity Stock Down 11.9 %

BTCY stock opened at $0.37 on Wednesday. Biotricity has a twelve month low of $0.19 and a twelve month high of $1.67. The stock has a market capitalization of $8.37 million, a price-to-earnings ratio of -0.28 and a beta of 1.22. The firm’s fifty day simple moving average is $0.34 and its two-hundred day simple moving average is $0.64.

Biotricity (NASDAQ:BTCY) last issued its quarterly earnings results on Monday, August 19th. The company reported ($0.49) earnings per share (EPS) for the quarter. The company had revenue of $3.20 million during the quarter.

Hedge Funds Weigh In On Biotricity

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC bought a new stake in shares of Biotricity, Inc. (NASDAQ:BTCY) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned 0.45% of Biotricity at the end of the most recent reporting period. Institutional investors and hedge funds own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.